Journals / Türk Nöroşirürji Dergsi / 2017 / Cilt: 27 - Sayı: 2

Molecular Biology of Pituitary Adenomas

Hipofiz Adenomlarının Moleküler Biyolojisi

Pages
185–190
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will focus on the oncogenes, tumor suppressor genes, cell cycle elements and microRNAs which have role in tumorigenesis process.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The tumorigenesis of pituitary adenomas is a complex multistep process in which many genetic and epigenetic changes, internal and external factors are involved.
📊
Key Findings & Data:Oncogenes, tumor suppressor genes, cell cycle elements, genetic mutations, epigenetic modifications, microRNAs play role in this process.
💡
Conclusion & Impact:In this review, we will focus on the oncogenes, tumor suppressor genes, cell cycle elements and microRNAs which have role in tumorigenesis process.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The tumorigenesis of pituitary adenomas is a complex multistep process in which many genetic and epigenetic changes, internal and external factors are involved. Oncogenes, tumor suppressor genes, cell cycle elements, genetic mutations, epigenetic modifications, microRNAs play role in this process. In this review, we will focus on the oncogenes, tumor suppressor genes, cell cycle elements and microRNAs which have role in tumorigenesis process.

Özet

Hipofiz adenomlarında tümörogenez çok basamaklı olup genetik ve epigenetik değişiklikler ile birçok iç ve dış faktörün yer aldığı karmaşık bir süreçtir. Bu süreçte onkogenler, tümör baskılayıcı genler, hücre döngüsü elemanları, genetik mutasyonlar, epigenetik modifikasyonlar, mikroRNA'lar rol oynamaktadır. Bu derlemede, tümörogenez sürecinde rolü olan onkogenler, tümör baskılayıcı genler, hücre döngüsü elemanlarına değinilerek mikroRNA'lar üzerinde durulacaktır.

🔖

Cite This Article

CEYLAN, S., ANIK, İ., ÇABUK, B., AKKOYUNLU, D. S. (2022). Molecular Biology of Pituitary Adenomas. Türk Nöroşirürji Dergsi, Cilt: 27 - Sayı: 2, 185–190. https://ajindex.com/articles/637434

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Al-Shraim M, Al-Gahtany M, Al-Otaibi M, Al-Ahmari A, Scheithauer BW, Lloyd R, Kovacs K: Molecular biology of pituitary tumors. Endokrinologist 14: 359-367, 2004 2. Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, Silva WA Jr, Moreira AC, Castro M: MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 94: 320-323, 2009 3. Beatriz M, Lopes S: Atlas of Sellar and Parasellar Lesions. Switzerland:Springer International Publishing, 2016: 33-37 4. Bengtsson D, Schrøder HD, Andersen M, Maiter D, Berinder K, Feldt Rasmussen U, Rasmussen ÅK, Johannsson G, Hoybye C, van der Lely AJ, Petersson M, Ragnarsson O, Burman P: Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. J Clin Endocrinol Metab 100: 1689-1698, 2015 5. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC: miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280-285, 2005 6. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC: Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210: 370-377, 2007 7. Butz H, Likó I, Czirják S, Igaz P, Khan MM, Zivkovic V, Bálint K, Korbonits M, Rácz K, Patócs A: Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J Clin Endocrinol Metab 95:E181-191, 2010 8. Chunhui L, Xie W, Wu D, Li Z, Li C, Zhang Y: Expression of cell-cycle regulators is associated with invasive behavior and poor prognosis in prolactinomas. Int J Clin Exp Pathol 9: 3245-3255, 2016 9. D'Angelo D, Esposito F, Fusco A: Epigenetic mechanisms leading to overexpression of HMGA Proteins in human pituitary adenomas. Front Med (Lausanne) 8: 39, 2015 10. Dworakowska D, Grossman AB: The molecular pathogenesis of corticotroph tumours. Eur J Clin Invest 42: 665-676, 2012 11. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE: The preva- lence of pituitary adenomas: A systematic review. Cancer 101:613-619, 2004 12. Ezzat S, Asa SL: Mechanisms of disease: The pathogenesis of pituitary tumors. Nat Clin Pract Endocrinol Metab 2: 220-230, 2006 13. Farrell WE: Epigenetics of pituitary tumours: An update. Curr Opin Endocrinol Diabetes Obes 21: 299-305, 2014 14. Gadelha MR, Trivellin G, Hernández Ramírez L